Safety and PK/PD of ALLO-647, an anti-CD52 antibody, with fludarabine (Flu)/cyclophosphamide (Cy) for lymphodepletion in the setting of allogeneic CAR-T cell therapy Meeting Abstract
| Authors: | Tees, M. T.; Neelapu, S. S.; Hari, P.; Mailankody, S.; Miklos, D. B.; Locke, F. L.; Nath, R.; Prashad, S. L.; Zhou, X.; Demirhan, E.; Nandakumar, S. P.; Fisher, D.; Opiteck, G.; Wang, E. |
| Abstract Title: | Safety and PK/PD of ALLO-647, an anti-CD52 antibody, with fludarabine (Flu)/cyclophosphamide (Cy) for lymphodepletion in the setting of allogeneic CAR-T cell therapy |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601049 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2527 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2527 -- Source: Wos |
